J. J. Patten

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Inhibition of HECT E3 ligases as potential therapy for COVID-19”.

Inhibition of HECT E3 ligases as potential therapy for COVID-19

Cell Death and Disease(2021)10.1038/s41419-021-03513-1

N/A

1.5DataRank · unranked

57 citations

Jing Liu, Michela Biancolella, Tonino Alonzi, Antonio Novelli, J. J. Patten +38 more

Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2025581118

N/A

0.942DataRank · unranked

534 citations

Ítalo Faria do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol +6 more

A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening

iScience(2021)10.1016/j.isci.2020.102021

N/A

0DataRank · unranked

91 citations

Krishna Mohan Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zifu Wang +32 more

Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site

Antiviral Research(2021)10.1016/j.antiviral.2021.105059

N/A

0DataRank · unranked

7 citations

Nicholas Y. Palermo, Leslie Estrada, Colton Thompson, J. J. Patten, Manu Anantpadma +3 more

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.20.440626

N/A

0DataRank · unranked

9 citations

Patrick T. Keiser, Deisy Morselli Gysi, Giulia Menichetti, Hiroyuki Mori, Callie J. Donahue +21 more

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization

iScience(2022)10.1016/j.isci.2022.104925

N/A

0DataRank · unranked

29 citations

Patrick T. Keiser, Deisy Morselli-Gysi, Giulia Menichetti, Hiroyuki Mori, Callie J. Donahue +21 more

Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy

Journal of Medical Virology(2022)10.1002/jmv.28157

N/A

0DataRank · unranked

22 citations

Mikołaj Słabicki, Sita Ramaswamy, J. J. Patten, Charles Zou, Chengcheng Meng +12 more

Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses

Antiviral Research(2022)10.1016/j.antiviral.2022.105399

N/A

0DataRank · unranked

5 citations

Leslie Estrada, Joshua Wiggins, Manu Anantpadma, J. J. Patten, Robert A. Davey +2 more

Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation

Viruses(2022)10.3390/v15010043

N/A

0DataRank · unranked

5 citations

Scott Seitz, Emily F. Gaudiano, J. J. Patten, Patrick T. Keiser, John H. Connor +3 more

The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein

iScience(2023)10.1016/j.isci.2023.106601

N/A

0DataRank · unranked

10 citations

Hojong Yoon, Paul M.C. Park, J. J. Patten, Jesse Pellman, Jeannie Carreiro +12 more

Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line

Viruses(2023)10.3390/v15102077

N/A

0DataRank · unranked

5 citations

Jonah Elliff, J. J. Patten, L. R. Wilson, Robert A. Davey, Adam L. Bailey +2 more

Design of universal Ebola virus vaccine candidates via immunofocusing

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2316960121

N/A

0DataRank · unranked

22 citations

Abigail E. Powell, Ashley Utz, Mrinmoy Sanyal, Jonathan Do, J. J. Patten +5 more

Ebola Virus Infection of Liver Cells: Effect of Interferon Gamma on Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line

Preprints.org(2023)10.20944/preprints202308.1977.v1

N/A

0DataRank · unranked

1 citations

Jonah Elliff, J. J. Patten, Lindsay R. Wilson, Robert A. Davey, Adam L. Bailey +2 more

Design of universal Ebola virus vaccine candidates via immunofocusing

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.14.562364

N/A

0DataRank · unranked

0 citations

Abigail E. Powell, Ashley Utz, Mrinmoy Sanyal, Jonathan Do, J. J. Patten +5 more

Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2

Molecular Cell(2020)10.1016/j.molcel.2020.11.028

N/A

0DataRank · unranked

131 citations

Adam J. Hume, Raghuveera Kumar Goel, Kristine M. Abo, Jessie Huang, Benjamin C. Blum +45 more

Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis

Antiviral Research(2024)10.1016/j.antiviral.2024.105976

N/A

0DataRank · unranked

5 citations

Wenhan Zhang, Michael Ricca, Alan Wacquiez, Autumn O Grimins, Regina Cencic +11 more

A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening

ChemRxiv(2020)10.26434/chemrxiv.12682316.v1

N/A

0DataRank · unranked

3 citations

Krishna Mohan Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zifu Wang +32 more